Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies
Authors:
- Usa ThisyakornUTUsa Thisyakorn
- Josefina CarlosJCJosefina Carlos
- Tawee ChotpitayasunondhTCTawee Chotpitayasunondh
- Tran M. DienTDTran M. Dien
- Maria Liza A. M. GonzalesMGMaria Liza A. M. Gonzales
- Nguyen T. L. HuongNHNguyen T. L. Huong
- Zulkifli IsmailZIZulkifli Ismail
- Anna Lisa T. Ong-LimAOAnna Lisa T. Ong-Lim
- Terapong TantawichienTerapong Tantawichien
- Sangita D. TerumalaySTSangita D. Terumalay
- Thiem D. VuTVThiem D. Vu
Open Access
- 9 September 2022
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (6) , 2110759
Abstract
Invasive meningococcal disease (IMD) imposes a significant burden on the global community due to its high case fatality rate (4-20%) and the risk of long-term sequelae for one in five survivors. An expert group meeting was held to discuss the epidemiology of IMD and immunization policies in Malaysia, Philippines, Thailand, and Vietnam. Most of these countries do not include meningococcal immunization in their routine vaccination programs, except for high-risk groups such as immunocompromised people and pilgrims. It is difficult to estimate the epidemiology of IMD in the highly diverse Asia-Pacific region, but available evidence indicate serogroup B is increasingly dominant. Disease surveillance systems differ by country. IMD is not a notifiable disease in some of them. Without an adequate surveillance system in the region, the risk and the burden of IMD might well be underestimated. With the availability of new combined meningococcal vaccines and the World Health Organization roadmap to defeat bacterial meningitis by 2030, a better understanding of the epidemiology of IMD in the Asia-Pacific region is needed.Keywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 28 references indexed in Scilit:
- Vaccine preventable meningitis in Malaysia: epidemiology and managementExpert Review of Anti-infective Therapy, 2015
- The burden and impact of severe and long-term sequelae of meningococcal diseaseExpert Review of Anti-infective Therapy, 2013
- An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in AsiaBMC Infectious Diseases, 2012
- Meningococcal carriage and disease—Population biology and evolutionVaccine, 2009
- Bacterial meningitis incidence in Thai children estimated by a rapid assessment tool (RAT).2009
- Serogroups and antibiotic susceptibility patterns of Neisseria meningitidis isolated from army recruits in a training camp.2007
- Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia.2006
- HAEMOPHILUS INFLUENZAE TYPE B MENINGITIS AMONG CHILDREN IN HANOI, VIETNAM: EPIDEMIOLOGIC PATTERNS AND ESTIMATES OF H. INFLUENZAE TYPE B DISEASE BURDENThe American Journal of Tropical Medicine and Hygiene, 2006
- Neisseria meningitidis isolates with moderate susceptibility to penicillin.2004
- Epidemiology of invasive meningococcal disease in 13 government hospitals in Thailand, 1994-1999.2000